UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of
Report (Date of earliest event reported)
June 8, 2021
________________________________
AEHR TEST SYSTEMS
(Exact
name of registrant as specified in its charter)
|
California
|
|
000-22893
|
|
94-2424084
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
|
||||
|
400 KATO TERRACE, FREMONT, CA 94539
|
||||
|
(Address
of principal executive offices, including zip code)
|
||||
|
|
||||
|
510-623-9400
|
||||
|
(Registrant’s
telephone number, including area code)
|
||||
|
|
||||
|
N/A
|
||||
|
(Former
name or former address, if changed since last report)
|
||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
Trading
|
Name of
each exchange on which registered
|
|
|
Symbol(s)
|
|
|
Common
Stock
|
AEHR
|
The
NASDAQ Capital Market
|
Item
5.02.
Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On June
8, 2021, the Compensation Committee of the Board of Directors (the
“Committee”) of Aehr Test Systems (the
“Company”) approved the elimination of the temporary
thirty percent (30%) salary reductions, and restoration of the base salaries
to those in effect prior to September 7, 2020, to the base salary
of its Chief Executive Officer, Chief Financial Officer and the
other Named Executive Officers (“NEOs”) disclosed in
the Company’s definitive proxy statement filed with the
Securities and Exchange Commission on September 24, 2020 (the
“Proxy Statement”). Such changes to be
effective May 31, 2021. All other forms of compensation paid
to NEOs are unchanged from the rates disclosed in the Proxy
Statement.
The information contained in Item 7.01 of this Form 8-K shall not
be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly provided by specific reference in
such a filing.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
Aehr Test
Systems
(Registrant)
|
|
|
|
|
|
|
|
|
Date:
June
10, 2021
|
By:
|
/s/ Kenneth B.
Spink
|
|
|
|
|
Kenneth B. Spink |
|
|
|
|
Vice
President of Finance and Chief Financial
Officer
|
|